Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A conversation with Arthur Kavanaugh.

Arthur Kavanaugh

    Managed Care Interface
    |September 14, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Biologic therapies are increasingly vital for treating autoimmune diseases. Research is exploring their use and genetic factors in rheumatoid arthritis management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    GRAPPA Debate: Is Plain Radiography in Psoriatic Disease Still Necessary?

    The Journal of rheumatology·2026
    Same author

    Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies.

    RMD open·2026
    Same author

    Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study.

    Cureus·2025
    Same author

    Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.

    Nature medicine·2025
    Same author

    Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs.

    The American journal of gastroenterology·2025
    Same author

    Challenges in Developing Treatment Guidelines in Psoriatic Arthritis.

    Rheumatic diseases clinics of North America·2025
    Same journal

    Changes in hospital readmissions for diabetes-related conditions. Differences by payer.

    Managed care interface·2008
    Same journal

    Heart disease and managed care.

    Managed care interface·2008
    Same journal

    A conversation with James K. Min, MD.

    Managed care interface·2008
    Same journal

    Acute coronary syndromes.

    Managed care interface·2008
    Same journal

    Improving outcomes in cardiovascular disease.

    Managed care interface·2008
    Same journal

    The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.

    Managed care interface·2008
    See all related articles

    Area of Science:

    • Immunology
    • Rheumatology
    • Pharmacology

    Background:

    • Biologic therapies have gained prominence in managing autoimmune conditions.
    • The discussion highlights the evolving role of these advanced treatments.

    Discussion:

    • Focus on the application of biologic agents in autoimmune disease treatment.
    • Exploration of ongoing research and future directions in the field.
    • Consideration of genetic factors influencing treatment efficacy, particularly in rheumatoid arthritis.

    Key Insights:

    • Biologics represent a significant advancement in autoimmune disease therapy.
    • Genetic predispositions can impact patient response to rheumatoid arthritis treatments.
    • Personalized medicine approaches are becoming crucial in rheumatology.

    Related Experiment Videos

    Outlook:

    • Continued research into novel biologic targets and mechanisms.
    • Integration of genetic profiling for tailored rheumatoid arthritis treatment strategies.
    • Advancements in biologics promise improved outcomes for autoimmune disease patients.